Acetone

Acetone

SCHEMBL3372800

CC(C)=O.N#CCC(O)CO

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
ALDH1A1 P00352 1/20 0.36
OR51E2 Q9H255 1/20 0.35
THRB P10828 1/20 0.31
MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetone SCHEMBL9175048 1.00 LMNA (0.36) LMNAALDH1A1OR51E2THRBMCL1
SCHEMBL7558453 0.87
SCHEMBL7560829 0.87
SCHEMBL1956609 0.87
Trimethylammonium SCHEMBL9465354 0.83 LMNA (0.38) LMNAALDH1A1THRB
Glycerin SCHEMBL10878473 0.79 LMNA (0.60) LMNAALDH1A1OR51E2THRB
Glycerin SCHEMBL8676320 0.76 LMNA (0.43) LMNAALDH1A1OR51E2THRB
SCHEMBL5610511 0.76
SCHEMBL8315661 0.76
Glycerin SCHEMBL93722 0.76 LMNA (0.64) LMNAALDH1A1OR51E2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1619191-B1 Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl] acetic acid derivatives KANEKA CORP (JP) 2010-10-27 EP disclosed
CN-100376682-C Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivatives KANEGAFUCHI CHEMICAL IND (JP) 2008-03-26 CN disclosed
EP-1394157-B1 Process for the preparation of 3,5-dihydroxy substituted esters as intermediates for producing optically active 2-(6-(hydroxymethyl)-1,3-dioxan-4-yl) acetic acid dervatives KANEKA CORP (JP) 2007-10-17 EP disclosed
EP-1288213-B1 PROCESS FOR PREPARING OPTICALLY ACTIVE 2- 6-(HYDROXY-METHYL)-1,3-DIOXAN-4-YL|ACETIC ACID DERIVATIVES KANEKA CORP (JP) 2006-11-29 EP disclosed
US-20060246557-A1 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives KANEKA CORPORATION (JP) 2006-11-02 US disclosed
US-7094594-B2 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives KANEKA CORPORATION (JP) 2006-08-22 US disclosed
EP-1619191-A2 Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl] acetic acid derivatives KANEKA CORPORATION (JP) 2006-01-25 EP disclosed
US-6903225-B2 Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivatives KANEKA CORPORATION (JP) 2005-06-07 US disclosed
US-20050080277-A1 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives KANEKA CORPORATION (JP) 2005-04-14 US disclosed
CN-1566351-A Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivatives KANEGAFUCHI CHEMICAL IND (JP) 2005-01-19 CN disclosed
CN-1162422-C Process for preparing optically active 2- [ 6- (hydroxymethyl) -1, 3-dioxan-4-yl ] acetic acid derivatives ��Ԩ��ѧ��ҵ��ʽ���� 2004-08-18 CN disclosed
EP-1024139-B1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 2-(6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YL) ACETIC ACID DERIVATIVES KANEKA CORP (JP) 2004-05-12 EP disclosed
EP-1394157-A2 Process for the preparation of 3,5-dihydroxy substituted esters as intermediates for producing optically active 2-(6-(hydroxymethyl)-1,3-dioxan-4-yl) acetic acid dervatives KANEKA CORPORATION (JP) 2004-03-03 EP disclosed
EP-1288213-A1 PROCESS FOR PREPARING OPTICALLY ACTIVE 2- 6-(HYDROXY-METHYL)-1,3-DIOXAN-4-YL]ACETIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2003-03-05 EP disclosed
US-20030040634-A1 Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4yl]acetic acid derivatives KANEKA CORPORATION (JP) 2003-02-27 US disclosed
US-6472544-B1 REACTING ACETIC ACID DERIVATIVE WITH AN ENOLATE, REDUCING WITH A MICROORGANISM, ACETALIZING IN PRESENCE OF ACID CATALYST THEN ALKALINE SAPONIFICATION; NO SPECIAL EQUIPMENT OR SUPER LOW TEMPERATURE REQUIRED; INEXPENSIVE STARTING MATERIALS KANEKA CORPORATION (JP) 2002-10-29 US disclosed
CN-1274356-A Process for preparing optically active 2- [ 6- (hydroxymethyl) -1, 3-dioxan-4-yl ] acetic acid derivatives KANEKA CHEMICAL IND CO LTD (JP) 2000-11-22 CN disclosed
EP-1024139-A1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 2- 6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YL]ACETIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2000-08-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030040634-A1 Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4yl]acetic acid derivatives HAAO, APEH, AADAC LMNA 2150/4885ALDH1A1 153/4885OR51E2 2560/4885
US-20060246557-A1 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives HAAO, APEH, HPD LMNA 2002/4885ALDH1A1 174/4885OR51E2 2112/4885
US-20050080277-A1 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives HAAO, APEH, HPD LMNA 1972/4885ALDH1A1 207/4885OR51E2 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.